Journal of Pharmaceutical Policy and Practice (Dec 2017)

Hypnotics use in children 0–18 months: moderate agreement between mother-reported survey data and prescription registry data

  • Ingvild Holdø,
  • Jørgen G. Bramness,
  • Marte Handal,
  • Leila Torgersen,
  • Ted Reichborn-Kjennerud,
  • Eivind Ystrøm,
  • Hedvig Nordeng,
  • Svetlana Skurtveit

DOI
https://doi.org/10.1186/s40545-017-0117-7
Journal volume & issue
Vol. 10, no. 1

Abstract

Read online

Background Different methods in pharmacoepidemiology can be used to study hypnotic use in children. But neither questionnaire-based data nor prescription records can be considered a “gold standard”. This study aimed to investigate the agreement between mother-reported questionnaire-based data and prescription record data for hypnotic drugs in children aged 0–18 months. The agreement was compared to the agreement for a group of antiepileptic drugs. Methods Prescription record data were collected from the Norwegian prescription database for 47,413 children also surveyed in the Norwegian mother and child cohort between 2005 and 2009. Agreement between in the two data sources was calculated using Cohens Kappa. Multinomial logistic regression was used to calculate the effect of sociodemographic variables on discrepancies in data sources. Results The agreement between mother-reported and dispensed hypnotics was less than 50% for all hypnotics. Sensitivity of reporting increased with number of filled prescriptions. The agreement of antiepileptic drugs was 92.9% in the same population. Of several sociodemographic factors only paternal educational level and maternal work situation was significantly related to agreement between prescription record and survey data. Conclusion There was a moderate agreement between reported use and dispensed hypnotic drugs for infants and toddlers. Results indicate that sociodemographic factors play only a minor role in explaining discrepancy.

Keywords